Home > Insider Trading > Filing (0001596771-16-000154)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1610092	Diplomat Pharmacy Inc.	DPLO	Retail-Drug Stores And Proprietary Stores (5912)	382063100

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1619008	A Atheer Kaddis	4100 S. Saginaw Street Flint MI 48507	Evp Of Sales & Strategic Align	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2016-09-15	20,000	$3.07	20,000	No	4	M	Direct
Common Stock	Disposition	2016-09-15	20,000	$30.12	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option to Acquire Common Stock	Disposition	2016-09-15	20,000	$0.00	20,000	$3.07

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
275,800		2019-04-01	No	4	M	Direct

Footnotes

The sale was effected pursuant to a 10b5-1 trading plan initially adopted by the reporting person on August 12, 2016. The plan provides for monthly sales of 20,000 shares of common stock at the market price. Shares that are not sold in a particular month will be available for sale in subsequent months under the plan. 100,000 shares remain available for sale under the plan, which is set to expire on March 15, 2017.
The price represents the weighted average price of the multiple transactions reported on this line. The shares were sold at prices ranging from $30.00 to $30.73 per share. Upon request by the SEC staff, the issuer or any securityholder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price.
The options were granted on April 1, 2009. The options began to vest in annual increments of 25% of the option grant on the one-year anniversary of the grant date, to be fully vested after four years. 100% of the options originally granted are currently vested and exercisable.